gliclazide has been researched along with Psoriasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, W; Hou, R; Jiao, J; Li, J; Li, X; Liang, N; Liang, Y; Wang, Y; Xing, J; Zhang, K | 1 |
| Fang, H; Gao, J; Guo, J; Mi, J; Mo, W; Nong, Y; Qi, Q; Yang, M | 1 |
| Chen, H; Chen, Y; Han, L; Liu, H; Lu, C; Tang, B; Yan, Y; Yu, J | 1 |
3 other study(ies) available for gliclazide and Psoriasis
| Article | Year |
|---|---|
Expression and functional regulation of gap junction protein connexin 43 in dermal mesenchymal stem cells from psoriasis patients.
Topics: Adolescent; Adult; Cell Communication; Cell Differentiation; Cell Proliferation; Cells, Cultured; Connexin 43; Energy Metabolism; Female; Gap Junctions; Glycolysis; Glycyrrhetinic Acid; Humans; Male; Mesenchymal Stem Cells; Middle Aged; Oxygen Consumption; Psoriasis; Young Adult | 2020 |
18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Topics: Animals; Apoptosis; Cell Line; Cytokines; Female; Glycyrrhetinic Acid; Humans; Imiquimod; Keratinocytes; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Psoriasis; Reactive Oxygen Species; Signal Transduction; Skin | 2020 |
The Protective Effects of 18
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Glycyrrhetinic Acid; Imiquimod; Immunohistochemistry; Inflammation Mediators; Mice; Protective Agents; Psoriasis; Signal Transduction; STAT3 Transcription Factor; T-Lymphocyte Subsets; TOR Serine-Threonine Kinases | 2020 |